Patents by Inventor Xiaojie Pan

Xiaojie Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230247866
    Abstract: Provided in the present disclosure are a display substrate and a preparation method therefor, and a display apparatus. The display substrate comprises a plurality of first pixel definition structures, second pixel definition structures, and third pixel definition structures; the first pixel definition structures each have an elongated shape extending along a first direction and are sequentially arranged along a second direction; the second pixel definition structures are disposed at intervals between the first pixel definition strictures, and at least one third pixel definition structure is disposed between the first pixel definition structures and the second pixel definition structures; and the height of the third pixel definition structures is less than the height of the second pixel definition structures.
    Type: Application
    Filed: March 9, 2022
    Publication date: August 3, 2023
    Inventors: Dejiang ZHAO, Xiaojie PAN
  • Patent number: 11541032
    Abstract: A composition containing SUMO inhibitor, and belongs to the technical field of medicine includes FXR agonist and SUMO inhibitor. In activated hepatic stellate cells, the FXR agonist does not have an effect in inhibiting the activation of hepatic stellate cells. After the FXR agonist and the SUMO inhibitor are compounded according to the present invention, the activation of hepatic stellate cells can also be inhibited for those cells under activated state. Of note, the hepatic stellate cells of an individual with hepatic fibrosis symptoms have been in an activated state, therefore a good anti-fibrotic effect cannot be achieved by using the FXR agonist alone.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: January 3, 2023
    Assignee: CHINA PHARMACEUTICAL UNIVERSITY
    Inventors: Haiping Hao, Hong Wang, Jiyu Zhou, Guangji Wang, Shuang Cui, Xiaojie Pan, Yitong Guo, Ningning Huang
  • Publication number: 20220339855
    Abstract: A folding device and a folding method are provided. The folding device includes a bearing and fixing mechanism configured to bear and fix a main body portion of a to-be-folded device; a folding mechanism disposed on at least one lateral side of the bearing and fixing mechanism, the folding mechanism being configured to bear a to-be-folded portion of the to-be-folded device and fold the to-be-folded portion to one side in a thickness direction of the main body portion; a first driving mechanism configured to drive the folding mechanism to move along a direction perpendicular to a bearing surface, which bears the main body portion, of the bearing and fixing mechanism; and a second driving mechanism configured to drive the folding mechanism to move close to or away from the bearing and fixing mechanism along a direction parallel to the bearing surface.
    Type: Application
    Filed: May 18, 2021
    Publication date: October 27, 2022
    Inventors: Shuqi LIU, Wenyue FU, Xinhong LU, Qi QI, Xiaojie PAN
  • Publication number: 20220097010
    Abstract: The present disclosure provides a gas-solid separation structure including: a feeding pipeline including a first feeding part, a second feeding part and a first valve disposed between the first and second feeding parts; a discharge pipeline having a first opening and a second opening opposite to each other, the second feeding part extending into the discharge pipeline via the first opening; wherein an exhaust channel is formed between the second feeding part and the discharge pipeline, exhaust holes are formed in a portion of the discharge pipeline opposite to the second feeding part, and the exhaust channel is in communication with the exhaust holes. The present disclosure further provides a feeding device and an electrochemical deposition apparatus. The present disclosure can improve the problem of interference with medicine powder release caused by gases entering the discharge pipeline.
    Type: Application
    Filed: August 23, 2021
    Publication date: March 31, 2022
    Inventors: Shaodong SUN, Junwei YAN, Guangcai YUAN, Guocai ZHANG, Shihao DONG, Lilei ZHANG, Haoran GAO, Wenyue FU, Chengfei WANG, Xiaojie PAN
  • Patent number: 11233101
    Abstract: The present disclosure provides a display substrate, a display device, and a method manufacturing of a display substrate, pertaining to the field of display devices. The display substrate includes a base substrate and a pixel defining layer. The pixel defining layer divides the base substrate into a plurality of sub-pixel regions. An orthographic projection of the at least one sub-pixel region on the base substrate is substantially quadrangular. The first side and the third side of the quadrilateral are inwardly recessed toward each other.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: January 25, 2022
    Assignee: BOE Technology Group Co., Ltd.
    Inventors: Dejiang Zhao, Yang Yang, Xiaojie Pan
  • Publication number: 20210028253
    Abstract: The present disclosure provides a display substrate, a display device, and a method manufacturing of a display substrate, pertaining to the field of display devices. The display substrate includes a base substrate and a pixel defining layer. The pixel defining layer divides the base substrate into a plurality of sub-pixel regions. An orthographic projection of the at least one sub-pixel region on the base substrate is substantially quadrangular. The first side and the third side of the quadrilateral are inwardly recessed toward each other.
    Type: Application
    Filed: May 31, 2018
    Publication date: January 28, 2021
    Inventors: Dejiang Zhao, Yang Yang, Xiaojie Pan
  • Publication number: 20200368199
    Abstract: A composition containing SUMO inhibitor, and belongs to the technical field of medicine includes FXR agonist and SUMO inhibitor. In activated hepatic stellate cells, the FXR agonist does not have an effect in inhibiting the activation of hepatic stellate cells. After the FXR agonist and the SUMO inhibitor are compounded according to the present invention, the activation of hepatic stellate cells can also be inhibited for those cells under activated state. Of note, the hepatic stellate cells of an individual with hepatic fibrosis symptoms have been in an activated state, therefore a good anti-fibrotic effect cannot be achieved by using the FXR agonist alone.
    Type: Application
    Filed: November 22, 2019
    Publication date: November 26, 2020
    Inventors: Haiping HAO, Hong WANG, Jiyu ZHOU, Guangji WANG, Shuang CUI, Xiaojie PAN, Yitong GUO, Ningning HUANG
  • Patent number: 10308036
    Abstract: Embodiments of the present disclosure provide a printhead, a printing equipment and a printing method. The printhead includes: a primary liquid discharging assembly, including a plurality of primary liquid discharging nozzles for forming primary droplets; and a plurality of flow branching components below the primary liquid discharging assembly, and the plurality of flow branching components being in one-to-one correspondence with the plurality of primary liquid discharging nozzles, wherein each of the plurality of flow branching component is configured to be in contact with the primary droplet formed by the corresponding primary liquid discharging nozzle of the plurality of primary liquid discharging nozzles, and split each of the primary droplets into at least two branched droplets.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: June 4, 2019
    Assignee: BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Dejiang Zhao, Yang Yang, Xiaojie Pan, Bin Bu
  • Publication number: 20190030912
    Abstract: Embodiments of the present disclosure provide a printhead, a printing equipment and a printing method. The printhead includes: a primary liquid discharging assembly, including a plurality of primary liquid discharging nozzles for forming primary droplets; and a plurality of flow branching components below the primary liquid discharging assembly, and the plurality of flow branching components being in one-to-one correspondence with the plurality of primary liquid discharging nozzles, wherein each of the plurality of flow branching component is configured to be in contact with the primary droplet formed by the corresponding primary liquid discharging nozzle of the plurality of primary liquid discharging nozzles, and split each of the primary droplets into at least two branched droplets.
    Type: Application
    Filed: April 25, 2018
    Publication date: January 31, 2019
    Inventors: Dejiang Zhao, Yang Yang, Xiaojie Pan, Bin Bu